Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
8.05
+0.51 (6.76%)
At close: Aug 13, 2025, 4:00 PM
8.05
0.00 (0.00%)
After-hours: Aug 13, 2025, 6:39 PM EDT
Prothena Corporation Employees
Prothena Corporation had 163 employees as of December 31, 2024. The number of employees decreased by 10 or -5.78% compared to the previous year.
Employees
163
Change (1Y)
-10
Growth (1Y)
-5.78%
Revenue / Employee
$63,442
Profits / Employee
-$1,858,399
Market Cap
433.33M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PRTA News
- 7 days ago - Prothena Announces that Novo Nordisk Will Advance Coramitug (Formerly PRX004) into Phase 3 Development for ATTR Amyloidosis with Cardiomyopathy - Business Wire
- 9 days ago - Prothena Reports Second Quarter 2025 Financial Results and Business Highlights - Business Wire
- 16 days ago - Prothena to Report Second Quarter 2025 Financial Results on August 4 - Business Wire
- 2 months ago - Prothena Announces Corporate Restructuring - Business Wire
- 2 months ago - Prothena's Partner Roche to Advance Prasinezumab into Phase III Development for Early-Stage Parkinson's Disease - Business Wire
- 2 months ago - Why Is Prothena Stock Trading Lower On Tuesday? - Benzinga
- 2 months ago - Prothena Announces Phase 3 AFFIRM-AL Clinical Trial for Birtamimab in Patients with AL Amyloidosis Did Not Meet Primary Endpoint - Business Wire
- 3 months ago - Top 3 Health Care Stocks That Are Preparing To Pump This Quarter - Benzinga